ArticleMethods in molecular biology (Clifton, N.J.)2017
Gold Nanorod Array Biochip for Label-Free, Multiplexed Biological Detection.
Article in Methods in molecular biology (Clifton, N.J.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 4 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Gold nanorod (GNR) based label-free sensing has been attractive due to its unique property of localized surface plasmon resonance (LSPR). Compared to bulk gold, the SPR of GNRs is more sensitive to the refractive index change caused by biological binding in the close proximity. Numerous studies have reported biological detection in solution based GNR probes. However, the biosensing has the intrinsic problems of fluctuating readings and short storage time due to nanoparticle aggregation. In contrast, a chip-based nanorod biosensor is a more robust and reliable platform. We have developed a nanoplasmonic biosensor in a chip format by immobilizing functionalized GNRs on a (3-mercaptopropyl)trimethoxysilane modified glass substrate. The covalent Au-S bond ensures a strong GNR deposition on the substrate. This biochip exhibits a high sensitivity and stability when exposed to physiological buffer with high ionic strength. Another advantage of GNR as optical transducer is its LSPR peak dependence on the aspect ratio, which provides an ideal multiplexed detection mechanism. GNRs of different sizes that exhibit distinct SPR peaks are combined and deposited on designated spots of a glass substrate. The spectral shift of the respective peaks upon the biological binding are monitored for simultaneous detection of specific analytes. Coupled with a microplate reader, this spatially resolved GNR array biochip results in a high-throughput assay of samples as well as multiplexed detection in each sample. Since most biological molecules such as antibodies and DNA can be linked to GNR using previously reported surface chemistry protocol, the label-free nanosensor demonstrated here is an effective tool for protein/DNA array analysis, especially for detection of disease biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.